LIfT BioSciences, (‘LIfT’ or ‘the Company’), a rapidly emerging biotech company about to start clinical trials for its first-in-class allogeneic innate cell therapy, today announces it has ...

Landmark is a groundbreaking three-year research programme that aims to understand Parkinson’s in unprecedented detail. The ...

Polydextrose Market The global polydextrose market share is likely to generate a revenue of nearly US$ 226.6 million in the ...

Addressing the industry leaders, PM Modi said that he always sees them as fellow travellers and co-partners in the ...

Regulators, policymakers and others can more effectively battle the disease by creating incentives to make mpox a more ...

The jury is currently out on whether pathology giant Healius will be better off without its Lumus imaging business.

Stockhead’s health and biotech expert Tim Boreham is back in the studio for another instalment of the Health Kick Podcast. ..

Partnerships between the U.S. and China at universities over the past decade have allowed hundreds of millions of dollars in ...

As a new regime and phase begin for the market and economy, after the FED cut interest rates by a surprising 50bps last ...

IPOs at three biotechs last week tempted insiders to make huge share purchases. This spilled over into buying at a couple of ...